Recombinant LEPR (Mibavademab Biosimilar) antibody

Catalog No. ABIN7597822

The Humanized Chimeric anti-LEPR (Mibavademab Biosimilar) antibody has been validated for . It is suitable to detect LEPR (Mibavademab Biosimilar) in samples from Human.

Quick Overview for Recombinant LEPR (Mibavademab Biosimilar) antibody (ABIN7597822)

Target: LEPR (Mibavademab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This LEPR (Mibavademab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-LEPR (Mibavademab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Mibavademab Biosimilar Antibody

Specificity: Leptin receptor, OB-R, LEP-R, LEPR, OB receptor, OBR, HuB219, DB, CD295

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for LEPR (Mibavademab Biosimilar)

Target: LEPR (Mibavademab Biosimilar)

Alternative Name: Mibavademab Biosimilar

Target Type: Biosimilar

Background: Leptin receptor, OB-R, LEP-R, LEPR, OB receptor, OBR, HuB219, DB, CD295

UniProt: P48357

CAS-No: 2305770-44-7